THREAD’s inVibe Solution Delivers Insights from 22,000 Unique Patients and HCPs to Accelerate Clinical Research and Healthcare Commercialization
New benchmarks demonstrate novel capabilities becoming the standard for large-scale voice insights enabling rapid co-creation with stakeholders by biopharma
CARY, N.C., 13 JAN 2026 – THREAD, a leading decentralized research and electronic clinical outcome assessment (eCOA) provider, today announced a major milestone for its patient and healthcare professional (HCP) voice-driven insights solution, inVibe. The platform has now engaged more than 22,000 unique patients and HCPs, establishing one of the industry’s largest and most diverse collections of stakeholder voice insights to support clinical development and healthcare commercialization.
Through inVibe, these 22,000 unique participants have shared more than 175,000 individual voice responses, offering an unprecedented level of scale, authenticity, and depth. Their contributions span over 8,000 research questions and represent more than 2,000 hours of spoken insight, giving biopharma companies and CROs direct access to lived experiences that are often lost in traditional research approaches.
“Reaching this milestone underscores the growing demand for authentic, real-time human perspectives in clinical research,” said John Reites, CEO and Co-founder. “Every voice we capture brings us closer to developing research studies and therapies that truly reflect the needs of patients and healthcare professionals. We are proud to enable more empathetic, evidence-driven decisions across our clients’ product lifecycles.”
inVibe’s proprietary speech technology platform with AI-assisted analysis enables deeper insights with quantified emotion, tone, and nuance at scale—attributes that traditional research methods often miss but provide meaningful data to enhance the quality of reporting. This allows sponsors to improve protocol design, optimize messaging, identify unmet needs, and ultimately bring more patient-centered solutions to market faster.
As inVibe continues to grow its technology capabilities, the company remains focused on advancing clinical research through the power of voice—ensuring that human experience guides innovation every step of the way.
To learn more about Patient and HCP Listening click here.
##
About THREAD
THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. Through its uniquely combined research technology and scientific consulting services, THREAD helps life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and human-centered.
THREAD has been recognized as a leader by Everest Group in its Decentralized Clinical Trial Product PEAK Matrix® Assessments from 2021 through 2023, is positioned in the Leaders Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment, and is named a Major Contender in Everest Group’s Life Sciences eCOA Products PEAK Matrix® Assessment 2025.
Media Contact
Les Yates
THREAD
media@THREADresearch.com